Valeric Acid Market By Grade (Industrial Grade, High-Purity Grade); By Application (Lubricants & Esters, Pharmaceutical Intermediates, Flavors & Fragrances, Agrochemicals, Others); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

How Large Is the Valeric Acid Market and Where Does Commercial Value Accrue?

The Global Valeric Acid Market was valued at USD 0.28 billion in 2025 and is projected to reach USD 0.43 billion by 2032, expanding at a CAGR of 6.3% during 2026-2032, according to Strategic Market Research. The forecast is mathematically consistent: USD 0.28 billion growing at approximately 6.3% for seven years reaches about USD 0.43 billion. Market value in this report refers to commercial sales of n-valeric acid/pentanoic acid itself, not the value of downstream lubricants, fragrances, pharmaceuticals, agrochemicals or finished valerate esters.

 

Valeric acid, also called n-valeric acid or pentanoic acid, is a five-carbon carboxylic acid with CAS 109-52-4. Commercially, it is purchased primarily as an intermediate: it is esterified into functional fluids and aroma chemicals, converted into acid derivatives for pharmaceutical or agrochemical synthesis, and supplied in qualified food/flavor or specialty grades. ASHRAE identifies valeric acid among the C5 acids commonly used to make polyol ester refrigeration lubricants, while FDA and JECFA recognize its food-flavor role under defined specifications. [1] [2] [3]

 

The commercial opportunity is becoming more mix-sensitive. Industrial grade still carries the larger volume base, but high-purity grade is forecast by SMR to grow faster at 7.7% as customers place greater value on controlled impurities, certificates of analysis, regulatory documentation and repeatable synthesis performance. In parallel, renewable and fermentation-derived products are creating a second axis of differentiation. Perstorp markets mass-balance renewable Valeric Acid Pro grades, ChainCraft markets >98% biobased X-Craft 5, and AFYREN is scaling a fermentation platform that had exceeded 1,000 tonnes of biobased acids produced since ramp-up by 27 August 2026. [4] [5] [6]

 

What Exactly Is Included in the SMR Valeric Acid Market?

Included	Commercial sales of n-valeric acid/pentanoic acid (CAS 109-52-4), including industrial/bulk, high-purity, food/flavor, specialty synthesis and commercially relevant laboratory or analytical formats.
Excluded	Isovaleric acid/3-methylbutanoic acid (CAS 503-74-2); finished valerate esters; valeryl chloride; finished POE lubricants; APIs; fragrances; formulated pesticides; and downstream product revenue.
Analyst-estimate note	Public trade codes do not isolate neat n-valeric acid cleanly. Regional shares and detailed segment splits are therefore SMR model outputs rather than directly reported customs totals. They should be read as triangulated market estimates, not government-measured values.

 

SMR methodology. The 2025 base, 2032 forecast and segment model are built from supplier/product mapping, application use intensity, commercial grade differentiation, pricing evidence, regional specialty-chemical activity, producer/distributor presence and downstream validation. Public facts from regulators, technical associations and company disclosures are used to explain market mechanisms. They are not used to manufacture false precision where direct product-level shipment data do not exist. This distinction is central to the report's E-E-A-T approach.

 

What Are the Key Valeric Acid Market Takeaways?

• By Grade - Industrial Grade: 74.0% of 2025 revenue, equivalent to about USD 0.207 billion; forecast CAGR 5.8%. The segment remains the scale base for recurring esterification and general intermediate chemistry.

• By Grade - High-Purity Grade: 26.0% of 2025 revenue, about USD 0.073 billion; forecast CAGR 7.7%. Faster growth reflects qualification-intensive pharmaceutical, food/flavor and specialty-synthesis requirements.

• By Application - Synthetic Lubricant & Functional Ester Intermediates: 45.0% share, about USD 0.126 billion; forecast CAGR 6.0%. POE lubricant chemistry remains the market's anchor application.

• By Application - Flavors & Fragrances: 25.0% share, about USD 0.070 billion; forecast CAGR 6.6%. Value is linked to established flavor regulation, valerate ester chemistry and specification-controlled supply.

• By Application - Pharmaceutical Intermediates: 18.0% share, about USD 0.050 billion; forecast CAGR 6.9%. Smaller in volume but strategically important because purity, documentation and process consistency can support higher value per unit.

• By Application - Agrochemicals: 9.0% share, about USD 0.025 billion; forecast CAGR 5.9%. Use is primarily as a specialty synthesis intermediate rather than a high-volume direct pesticide active.

• By Region - Asia Pacific: SMR estimates approximately 34.0% of 2025 revenue and a 6.9% CAGR, supported by specialty-chemical, pharmaceutical, flavor/fragrance and industrial synthesis ecosystems.

• Competitive structure: Established producers such as Perstorp and OXEA compete on scale, supply reliability and application portfolios; biobased platforms including AFYREN, ChainCraft and BioVeritas compete on route, carbon profile and qualification potential; reagent suppliers serve the fragmented high-purity tail.

 

Why Do Synthetic Lubricants and Ester Chemistry Anchor Market Revenue?

Synthetic lubricant and functional ester intermediates represented an estimated 45.0% of the market in 2025 and are forecast to grow at 6.0%. The commercial mechanism is direct: valeric acid is one of the linear C5 acids used in polyol ester chemistry, where formulators combine neopolyols and carboxylic-acid mixtures to tune viscosity, polarity, solubility and refrigerant compatibility. ASHRAE's 2026 Refrigeration Handbook explicitly lists valeric acid among the common carboxylic acids used in POE refrigeration lubricants. [1]

 

This creates a qualification-driven rather than purely spot-commodity market. Refrigerant architecture is changing under both the EU fluorinated-greenhouse-gas framework and the U.S. AIM Act technology-transition rules. These policies do not mandate valeric acid, but they change refrigerant and equipment choices and can trigger lubricant reformulation and requalification. In the United States, EPA sector restrictions include 2026 GWP limits for several industrial-process refrigeration categories, while the EU framework progressively restricts high-GWP fluorinated gases in refrigeration and air-conditioning equipment. [7] [8]

 

For suppliers, the implication is that application know-how and reproducible acid quality matter alongside price. Perstorp positions high-purity acids for synthetic ester base stocks and offers both conventional and renewable-content valeric acid. OXEA competes through a broader oxo-intermediates and carboxylic-acid platform serving lubricant, pharmaceutical, flavor/fragrance and other specialty markets. The best-positioned suppliers are therefore those able to deliver recurring commercial volumes while meeting formulation-specific quality and documentation requirements. [9] [10]

 

Why Is High-Purity Valeric Acid Growing Faster Than Industrial Grade?

High-Purity Grade accounted for an estimated 26.0% of 2025 revenue and is projected to expand at 7.7%, compared with 5.8% for Industrial Grade. The distinction is economic rather than merely analytical: where valeric acid enters API, agrochemical, food/flavor or tightly controlled specialty synthesis, downstream manufacturers incur qualification, impurity-management and documentation costs that make consistency more valuable than the lowest nominal acid price.

 

Perstorp's Valeric Acid Pure is positioned specifically for demanding API and agrochemical production, including acid-chloride routes such as valeryl chloride. In food and flavor applications, JECFA lists valeric acid as flavouring substance No. 90 with a minimum assay of 99.0%, and Sigma-Aldrich currently sells a >=99% FCC/flavor-grade material that references JECFA/FCC and FDA requirements. These commercial formats demonstrate that the market contains distinct value tiers rather than one homogeneous commodity grade. [11] [3] [12]

 

The fragmented specialty layer also includes Thermo Fisher Scientific, Tokyo Chemical Industry, FUJIFILM Wako, Chem-Impex, LGC Standards and other distributors or reagent suppliers. Their role should not be confused with world-scale bulk production: they broaden accessibility for laboratory, analytical, flavor and smaller-volume synthesis customers, often in kilogram or sub-bulk formats. TCI, for example, lists >98% valeric acid with certificates and documented specifications, while Thermo Fisher identifies its product primarily as a laboratory chemical. [13] [14]

 

How Do Flavor, Fragrance, Pharmaceutical and Agrochemical Uses Support Market Mix?

Flavors & Fragrances represented an estimated 25.0% of the market in 2025 and are forecast to grow at 6.6%. Valeric acid itself has a penetrating rancid odor, but it is commercially relevant as a recognized flavoring substance and as a precursor to valerate esters used in aroma chemistry. FDA identifies CAS 109-52-4 as a flavoring agent or adjuvant under 21 CFR 172.515, while JECFA specifies identity and purity parameters. The value opportunity therefore lies in qualified material and downstream ester chemistry, not in treating neat valeric acid as a pleasant fragrance ingredient. [2] [3]

 

Pharmaceutical Intermediates accounted for an estimated 18.0% of revenue and are forecast to grow at 6.9%. Here, the commercial value is driven by validated synthesis routes, repeatable impurity profiles and reliable documentation. Valeric acid can be converted into acid chlorides and related derivatives used in active-ingredient and specialty synthesis. Although this segment is smaller than lubricant chemistry by revenue, it is strategically important because qualification can create switching friction and support higher-value supply relationships.

 

Agrochemicals represented an estimated 9.0% of the market and are forecast to grow at 5.9%. The principal opportunity is as a chemical intermediate for specialty agricultural molecules and derivatives. EPA separately permits normal valeric acid as an inert pesticide ingredient for a narrowly defined stenching/odorant use at no more than 2% and also documents its role as an intermediate in flavors, perfumes, ester lubricants, plasticizers and vinyl stabilizers. The report therefore treats direct pesticide-formulation use as a niche and avoids inflating the agrochemical segment with the value of finished crop-protection products. [15]

 

Which Regulatory and Qualification Requirements Shape Commercial Access?

Valeric acid is not governed by one global product-specific regime; requirements depend on end use, geography and concentration. In U.S. food applications, FDA lists valeric acid (CAS 109-52-4) as a flavoring agent or adjuvant and references 21 CFR 172.515 and 173.315. The latter should be interpreted narrowly: it concerns a specified aliphatic-acid mixture used in lye-peeling solutions, not a blanket authorization for every food use. JECFA separately specifies valeric acid as flavouring substance No. 90 with a minimum assay of 99.0%. [2] [3]

 

For pesticides, EPA's inert-ingredient reassessment documents normal valeric acid as an odorant/stenching agent at not more than 2% in formulations and identifies CAS 109-52-4 under the relevant reassessment framework. In Europe, chemical supply is also subject to REACH registration, classification, safety-data-sheet and downstream use obligations. For commercial suppliers, these frameworks translate into grade qualification, traceable certificates, safety documentation and customer-specific approval requirements rather than a single universal "valeric acid standard." [15]

 

What Do 2026 Price Actions Reveal About Valeric Acid Economics?

2026 supplier actions show that market revenue is sensitive to more than end-use volume. On 19 March 2026, Perstorp announced a total n-valeric-acid increase of EUR 300/metric ton in Europe, USD 0.10/lb in the United States and USD 500/metric ton in the rest of the world, citing sharply higher raw-material and energy prices and supply-demand changes. OXEA had announced a total n-valeric-acid increase effective 13 March 2026 of EUR 170/metric ton in Europe, USD 200/metric ton in the rest of the world and USD 0.09/lb in North America, citing raw-material, energy, supply-chain costs and market volatility. [16] [17]

 

These actions do not establish an average global transaction price, but they are high-quality evidence that the revenue CAGR can be influenced by feedstock and energy inflation, supply tightness and contract resets. For management teams, the implication is that a 6.3% market-value CAGR should not be interpreted as an equivalent physical-volume CAGR. The market can grow through a combination of underlying consumption, higher-purity mix, renewable-product premiums and price normalization or escalation. Conversely, easing feedstock conditions could reduce nominal revenue growth even if tonnage remains stable.

 

How Is Biobased Valeric Acid Changing the Competitive Set?

Lower-carbon supply is evolving from a niche sustainability claim into a practical qualification question. Perstorp's Valeric Acid Pro 100 uses a traceable mass-balance model and is positioned as a renewable-content drop-in product. ChainCraft markets X-Craft 5 as >98% pure biobased valeric acid produced through its chain-elongation platform. BioVeritas identifies valeric acid among the C5-C8 volatile fatty acids produced by its fermentation and low-energy acid-recovery technology, with target markets including specialty/industrial chemicals and lubricants. [4] [5] [18]

 

AFYREN is one of the most visible industrial-scale fermentation entrants. On 27 August 2026, it reported that AFYREN NEOXY had exceeded 1,000 tonnes of biobased acids produced since ramp-up began; demonstrated capacity had reached 30% on multiple occasions and 40% over a 48-hour period following June works. Earlier in June, the company said first-half 2026 NEOXY revenue was approximately EUR 1 million, double full-year 2025 revenue, although the plant remained far below full capacity. [6] [19]

 

The strategic issue is not whether every customer will pay a green premium. It is whether lower-carbon material can qualify as a functionally equivalent feedstock without creating unacceptable formulation, purity, supply-security or cost trade-offs. If qualification broadens, renewable material can become a procurement and Scope 3 differentiator in synthetic lubricants, aroma chemicals and specialty synthesis. If scale-up economics remain difficult, conventional producers with renewable mass-balance options may retain an advantage because they combine established supply reliability with a lower-carbon product pathway.

 

Which Regions Offer the Strongest Commercial Opportunity?

Asia Pacific is estimated by SMR to account for approximately 34.0% of 2025 revenue, equivalent to about USD 0.095 billion, and to grow at an estimated 6.9% CAGR. The region combines large specialty-chemical and pharmaceutical manufacturing ecosystems with flavor/fragrance production, industrial formulation and dense reagent distribution. The 34% share is an SMR allocation, not a directly reported customs statistic; public product availability from suppliers such as TCI helps validate regional access but does not independently prove the market share. [13]

 

Europe is estimated at approximately 30.0% of the market, or USD 0.084 billion in 2025, with an estimated 6.4% CAGR. Europe has an unusually broad competitive structure: Perstorp and OXEA provide established conventional supply, Perstorp also offers renewable mass-balance grades, and AFYREN and ChainCraft represent differentiated fermentation/circular routes. The EU F-gas transition also keeps lubricant compatibility and POE formulation work commercially relevant, though regulation acts indirectly through refrigerant and equipment changes rather than mandating valeric acid itself. [7]

 

North America is estimated at 26.0% of 2025 revenue, about USD 0.073 billion, with an estimated 5.8% CAGR. Commercial use spans industrial refrigeration and engineered fluids, pharmaceutical and specialty synthesis, flavors/fragrances and reagent distribution. U.S. AIM Act technology-transition restrictions provide an additional reformulation catalyst in refrigeration, while BioVeritas adds an emerging domestic bioprocess pathway to a market historically served through established global chemical supply networks. [8] [18]

 

Latin America is estimated at 6.0% of the market and the Middle East & Africa at 4.0%. These two regions should be viewed primarily as smaller downstream consumption pools with greater dependence on imported specialty chemicals and distributors. SMR expects steady growth from food/flavor, industrial fluids and specialty synthesis, but the public evidence base does not justify presenting highly granular country shares. For publication, the regional numbers should remain clearly labelled as analyst estimates.

 

How Is the Valeric Acid Competitive Landscape Structured?

Competition is best understood in three layers rather than as one flat list. The first layer is established industrial production, where Perstorp and OXEA compete through oxo/carboxylic-acid platforms, recurring bulk supply, application support and global commercial reach. OQ Chemicals returned to the OXEA name on 19 May 2025 following its ownership change, so current 2026 reporting should use OXEA (formerly OQ Chemicals on first reference) rather than the stale OQ Chemicals name. [20]

 

The second layer is renewable or fermentation-based supply. Perstorp provides renewable-content mass-balance variants within an established conventional portfolio; AFYREN is ramping industrial fermentation; ChainCraft markets >98% X-Craft 5; and BioVeritas is developing a C5-C8 VFA platform. These companies should not be treated as commercially identical: their routes, scale, product slate, feedstocks, qualification status and customer economics differ materially.

 

The third layer is the specialty/reagent channel. Merck/Sigma-Aldrich, Thermo Fisher Scientific, Tokyo Chemical Industry, FUJIFILM Wako, Chem-Impex, LGC Standards, Spectrum Chemical and other distributors expand availability for laboratory, analytical, food/flavor and smaller-volume synthesis customers. Their competitive advantages are documentation, pack-size flexibility, regional inventory and channel reach rather than world-scale acid manufacturing.

 

Company	Competitive layer	Valeric-acid positioning	Relevant markets	Strategic differentiation
Perstorp	Industrial + renewable	Standard, Pure, Pro 20, Pro 100	POE lubricants, API/agro, specialty synthesis	Established supply plus purity and renewable mass-balance portfolio
OXEA	Industrial	Carboxylic-acid / oxo platform	Lubricants, pharma, flavors & fragrances, specialty chemicals	Global oxo platform, recurring industrial supply, pricing power
AFYREN	Biobased emerging	Fermentation-derived organic acids including valeric acid	Lubricants, flavors/fragrances, life sciences, materials	Industrial fermentation ramp-up and circular feedstock model
ChainCraft	Biobased emerging	X-Craft 5 >98% biobased valeric acid	Alcohol derivatives, lubricants, specialty chemicals	Chain-elongation technology and fractionated C5 product
BioVeritas	Biobased development	C5-C8 VFA platform including valeric acid	Lubricants, specialty chemicals, fuels pathway	Fermentation plus low-energy acid recovery
Sigma-Aldrich / Merck	Specialty channel	FCC/flavor, natural and analytical/reagent formats	Flavor, fragrance, analytical, research	High documentation and pack-size breadth
Thermo Fisher / TCI	Specialty channel	Laboratory/reagent grades	Research and specialty synthesis	Regional inventory, certificates and flexible formats

 

What Could Cause the 2032 Forecast to Miss?

• Feedstock and energy volatility: 2026 price actions show that producer economics can move quickly. A sustained cost shock can lift nominal market value while squeezing downstream margins; a reversal can do the opposite.

• Substitution within ester formulations: POE formulators can combine multiple linear and branched acids. Valeric acid is relevant, but it is not the only C5-C10 acid available, so relative performance and price matter.

• Biobased scale-up execution: Fermentation routes can create differentiated carbon profiles, but commercialization depends on reliable output, purification economics, customer qualification and repeatable product quality.

• Qualification cycles: Pharmaceutical, food/flavor and engineered-fluid customers can be slow to approve new sources. This protects incumbents but can delay new entrants even when chemistry is technically suitable.

• Data opacity: Product-specific global shipment and customs data are limited. Precise regional and application shares therefore carry higher model uncertainty than markets with dedicated tariff codes and publicly disclosed capacities.

 

What Is SMR's Analyst Perspective Through 2032?

SMR expects the Valeric Acid Market to remain a specialized intermediate market rather than become a high-volume commodity growth story. The most defensible expansion pathway is a combination of steady ester and synthesis consumption, faster growth in specification-sensitive grades, pricing/mix effects and gradual qualification of lower-carbon supply. That is why the market can plausibly reach USD 0.43 billion by 2032 at a 6.3% revenue CAGR even without a step-change in global physical tonnage.

 

The strongest profit pools are likely to sit where suppliers solve a customer qualification problem: repeatable POE performance, controlled pharmaceutical intermediates, documented food/flavor material, secure logistics or a credible lower-carbon drop-in route. Conventional producers retain meaningful advantages in scale and supply reliability, but emerging fermentation platforms are widening the strategic choice set. The critical commercial question for 2026-2032 is whether biobased valeric acid can move from selective qualification to recurring contracted volumes without sacrificing economics or consistency.

 

For CEOs and strategy teams, the market should therefore be monitored through five indicators rather than headline CAGR alone: supplier price actions; POE/refrigeration qualification activity; high-purity grade mix; biobased plant utilization and customer conversion; and any new disclosed capacity or long-term offtake agreement. Those indicators will reveal whether future value creation is being driven primarily by volume, pricing, specification mix or production-route transition.

 

Valeric Acid Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 0.28 Billion
Revenue Forecast in 2032	USD 0.43 Billion
Overall Growth Rate	CAGR of 6.3% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
Segmentation	By Grade, Application, Geography
By Grade	Industrial Grade, High-Purity Grade
By Application	Lubricants & Esters, Pharmaceutical Intermediates, Flavors & Fragrances, Agrochemicals, Others
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	U.S., Canada, Germany, UK, France, China, India, Japan, South Korea, Brazil, Mexico, GCC Countries, South Africa, etc.
Market Drivers	Rising use of valeric acid in synthetic lubricant and functional ester chemistry. Growth in high-purity material for pharmaceutical, food/flavor, and specialty synthesis applications. Increasing qualification of renewable and fermentation-derived valeric acid. Expanding specialty-chemical, pharmaceutical, and flavor & fragrance manufacturing activity across Asia-Pacific.
Customization Option	Available upon request